China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Health Management Needs and Navigation Matrix Model for Patients with Kidney Cancer Undergoing Immune- Targeted Therapy from the Perspective of Journey Maps'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132849

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342815

Published by HT Digital Content Services with permission from Health Daily Digest....